Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC.

Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Review.

2.

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D.

Blood. 2018 Nov 1;132(18):1871-1878. doi: 10.1182/blood-2018-04-842559. Epub 2018 Aug 6. Review.

PMID:
30082493
3.

Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.

Vaisitti T, Braggio E, Allan JN, Arruga F, Serra S, Zamò A, Tam W, Chadburn A, Furman RR, Deaglio S.

Cancer Res. 2018 Jul 1;78(13):3413-3420. doi: 10.1158/0008-5472.CAN-17-4004. Epub 2018 May 7.

PMID:
29735551
4.

KSHV induces immunoglobulin rearrangements in mature B lymphocytes.

Totonchy J, Osborn JM, Chadburn A, Nabiee R, Argueta L, Mikita G, Cesarman E.

PLoS Pathog. 2018 Apr 16;14(4):e1006967. doi: 10.1371/journal.ppat.1006967. eCollection 2018 Apr.

5.

Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.

Nam AS, Giorgadze T, Tam W, Chadburn A.

Acta Cytol. 2018;62(2):130-136. doi: 10.1159/000487070. Epub 2018 Mar 6.

PMID:
29510385
6.

The effect of the acute phase response on routine laboratory markers of folate and vitamin B12 status.

Parkes JP, Wood L, Chadburn AJ, Garman E, Abbas R, Modupe A, Whitehead SJ, Ford C, Thomas OL, Chugh S, Deshpande S, Gama R.

Int J Lab Hematol. 2018 Apr;40(2):e21-e23. doi: 10.1111/ijlh.12778. Epub 2018 Feb 5. No abstract available.

PMID:
29405641
7.

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS.

Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.

8.

Resolution of a steroid-resistant, hypereosinophilic immune diathesis with mepolizumab and concomitant amelioration of a mixed thrombotic microangiopathy.

Mulvey JJ, Magro C, Chadburn A.

Blood Cells Mol Dis. 2018 Mar;69:38-42. doi: 10.1016/j.bcmd.2017.04.008. Epub 2017 May 2.

PMID:
28648630
9.

Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.

Giulino-Roth L, van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, Bolaender A, Erdjument-Bromage H, Sadek J, Chadburn A, Barth MJ, Dela Cruz FS, Rainey A, Kung AL, Chiosis G, Cesarman E.

Mol Cancer Ther. 2017 Sep;16(9):1779-1790. doi: 10.1158/1535-7163.MCT-16-0848. Epub 2017 Jun 15.

10.

The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>.

Rutherford SC, Stewart EN, Chen Z, Chadburn A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L.

Leuk Lymphoma. 2018 Jan;59(1):256-258. doi: 10.1080/10428194.2017.1323270. Epub 2017 Jun 2. No abstract available.

PMID:
28573908
11.

Fructosamine: A Negative Acute Phase Reactant.

Garman E, Chadburn AJ, Abbas R, Modupe A, Thomas OL, Chugh S, Deshpande S, Ford C, Gama R.

J Diabetes Sci Technol. 2018 Jan;12(1):234-235. doi: 10.1177/1932296817712527. Epub 2017 May 31. No abstract available.

12.

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, Leppa S, Mannisto S, Kovanen PE, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Iqbal J, Yu J, Naresh K, Villa D, Gascoyne RD, Said J, Czader MB, Chadburn A, Richards KL, Rajagopalan D, Davis NS, Smith EC, Palus BC, Tzeng TJ, Healy JA, Lugar PL, Datta J, Love C, Levy S, Dunson DB, Zhuang Y, Hsi ED, Dave SS.

J Exp Med. 2017 May 1;214(5):1371-1386. doi: 10.1084/jem.20160894. Epub 2017 Apr 19.

13.

B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2.

de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):153-170. doi: 10.1093/ajcp/aqw216.

14.

EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES.

Am J Clin Pathol. 2017 Feb 1;147(2):129-152. doi: 10.1093/ajcp/aqw214.

15.

Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):204-216. doi: 10.1093/ajcp/aqw215.

16.

T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4.

Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, Said J, Natkunam Y.

Am J Clin Pathol. 2017 Feb 1;147(2):188-203. doi: 10.1093/ajcp/aqw213.

17.

HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.

Chadburn A, Said J, Gratzinger D, Chan JK, de Jong D, Jaffe ES, Natkunam Y, Goodlad JR.

Am J Clin Pathol. 2017 Feb 1;147(2):171-187. doi: 10.1093/ajcp/aqw218.

18.

Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology.

Natkunam Y, Gratzinger D, de Jong D, Chadburn A, Goodlad JR, Chan JK, Said J, Jaffe ES.

Am J Clin Pathol. 2017 Feb 1;147(2):124-128. doi: 10.1093/ajcp/aqw200. No abstract available.

PMID:
28395103
19.

The impact of between analytical platform variability on the classification of pleural effusions into exudate or transudate using Light's criteria.

Cornes MP, Chadburn AJ, Thomas C, Darby C, Webster R, Ford C, Gama R.

J Clin Pathol. 2017 Jul;70(7):607-609. doi: 10.1136/jclinpath-2016-204142. Epub 2017 Feb 16.

PMID:
28209662
20.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Davé SS.

Cancer Discov. 2017 Apr;7(4):369-379. doi: 10.1158/2159-8290.CD-16-0330. Epub 2017 Jan 25.

21.

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS.

Blood. 2017 Mar 23;129(12):1646-1657. doi: 10.1182/blood-2016-10-746933. Epub 2017 Jan 13.

22.

Effect of the systemic inflammatory response, as provoked by elective orthopaedic surgery, on HbA1c.

Chadburn AJ, Garman E, Abbas R, Modupe A, Ford C, Thomas OL, Chugh S, Deshpande S, Gama R.

Ann Clin Biochem. 2017 Jul;54(4):504-506. doi: 10.1177/0004563216682536. Epub 2017 Jan 13.

PMID:
27856516
23.

Corrigendum: Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells.

Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A.

Nat Immunol. 2016 Sep 20;17(10):1235. doi: 10.1038/ni1016-1235a. No abstract available.

PMID:
27648550
24.

Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia.

Pizzi M, Covey S, Mathew S, Liu YC, Ruan J, Leonard JP, Chadburn A.

Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):e47-50. doi: 10.1016/j.clml.2015.11.019. Epub 2015 Nov 26. No abstract available.

PMID:
26708981
25.

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.

Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A.

Leuk Lymphoma. 2016 Jul;57(7):1731-4. doi: 10.3109/10428194.2015.1113281. Epub 2015 Dec 16. No abstract available.

26.

Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease.

DeSimone RA, Mitsios JV, Kucine N, Goss CA, Chadburn A, Cushing MM.

Transfusion. 2015 Oct;55(10):2304. doi: 10.1111/trf.13177. No abstract available.

PMID:
26459962
27.

The tumor virus landscape of AIDS-related lymphomas.

Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E.

Blood. 2015 May 14;125(20):e14-22. doi: 10.1182/blood-2014-11-599951. Epub 2015 Mar 31.

28.

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E, Roshal M.

Blood. 2015 Feb 12;125(7):1061-72. doi: 10.1182/blood-2014-11-610436. Epub 2014 Dec 8.

29.

Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event.

Gandhi MD, Evens AM, Fenske TS, Hamlin P, Coiffier B, Engert A, Moskowitz AJ, Ghosh N, Petrich AM, Lomasney J, Chadburn A, Wood GS, Salva K, Nardone B, Trifilio SM, Raisch DW, West DP, Gordon LI, Winter JN.

Blood. 2014 May 1;123(18):2895-7. doi: 10.1182/blood-2014-03-561878. No abstract available.

30.

Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1.

Johnson AA, Lee YS, Chadburn AJ, Tammaro P, Manson FD, Marmorstein LY, Marmorstein AD.

Exp Eye Res. 2014 Apr;121:74-85. doi: 10.1016/j.exer.2014.02.006. Epub 2014 Feb 19. Erratum in: Exp Eye Res. 2014 Oct;127:300.

31.

Genetics of follicular lymphoma transformation.

Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbò F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, Inghirami G, Malek SN, Rabadan R, Dalla-Favera R.

Cell Rep. 2014 Jan 16;6(1):130-40. doi: 10.1016/j.celrep.2013.12.027. Epub 2014 Jan 2.

32.

Bone marrow involvement by subcutaneous panniculitis-like T-cell lymphoma: a report of three cases.

Gao J, Gauerke SJ, Martinez-Escala ME, Guitart J, Nelson BP, Chadburn A, Peterson LC.

Mod Pathol. 2014 Jun;27(6):800-7. doi: 10.1038/modpathol.2013.191. Epub 2013 Nov 8.

33.

Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.

Clozel T, Yang S, Elstrom RL, Tam W, Martin P, Kormaksson M, Banerjee S, Vasanthakumar A, Culjkovic B, Scott DW, Wyman S, Leser M, Shaknovich R, Chadburn A, Tabbo F, Godley LA, Gascoyne RD, Borden KL, Inghirami G, Leonard JP, Melnick A, Cerchietti L.

Cancer Discov. 2013 Sep;3(9):1002-19. doi: 10.1158/2159-8290.CD-13-0117. Epub 2013 Aug 16.

34.

Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9.

Smith KJ, Chadburn AJ, Adomaviciene A, Minoretti P, Vignali L, Emanuele E, Tammaro P.

Int J Cardiol. 2013 Oct 9;168(4):3506-13. doi: 10.1016/j.ijcard.2013.04.210. Epub 2013 Jun 3.

PMID:
23739550
35.

Molecular and immunohistochemical detection of Kaposi sarcoma herpesvirus/human herpesvirus-8.

Chadburn A, Wilson J, Wang YL.

Methods Mol Biol. 2013;999:245-56. doi: 10.1007/978-1-62703-357-2_18.

PMID:
23666704
36.

Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8).

Chadburn A.

Semin Diagn Pathol. 2013 May;30(2):113-29. doi: 10.1053/j.semdp.2012.08.006. Epub 2013 Mar 26. Review.

PMID:
23537912
37.

Lymphoid proliferations associated with human immunodeficiency virus infection.

Chadburn A, Abdul-Nabi AM, Teruya BS, Lo AA.

Arch Pathol Lab Med. 2013 Mar;137(3):360-70. doi: 10.5858/arpa.2012-0095-RA. Review.

PMID:
23451747
38.

Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.

Roberts MJ, Chadburn A, Ma S, Hyjek E, Peterson LC.

Am J Clin Pathol. 2013 Feb;139(2):210-9. doi: 10.1309/AJCP0YGM8BLFYHJY.

PMID:
23355206
39.

Genetic heterogeneity of diffuse large B-cell lymphoma.

Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403. doi: 10.1073/pnas.1205299110. Epub 2013 Jan 4.

40.

Parametrisation of the free energy of ATP binding to wild-type and mutant Kir6.2 potassium channels.

Moran O, Grottesi A, Chadburn AJ, Tammaro P.

Biophys Chem. 2013 Jan;171:76-83. doi: 10.1016/j.bpc.2012.10.006. Epub 2012 Nov 16.

PMID:
23219002
41.

The genetic landscape of mutations in Burkitt lymphoma.

Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS.

Nat Genet. 2012 Dec;44(12):1321-5. doi: 10.1038/ng.2468. Epub 2012 Nov 11.

42.

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED; Cancer Leukemia Group B.

Haematologica. 2012 May;97(5):758-65. doi: 10.3324/haematol.2011.056531. Epub 2011 Dec 1.

43.

Analysis of the coding genome of diffuse large B-cell lymphoma.

Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R.

Nat Genet. 2011 Jul 31;43(9):830-7. doi: 10.1038/ng.892.

44.

Clinical, morphologic, immunophenotypic, and molecular cytogenetic assessment of CD4-/CD8-γδ T-cell large granular lymphocytic leukemia.

Chen YH, Chadburn A, Evens AM, Winter JN, Gordon LI, Chenn A, Goolsby C, Peterson L.

Am J Clin Pathol. 2011 Aug;136(2):289-99. doi: 10.1309/AJCPTFFQ18JMYKDF.

PMID:
21757603
45.

A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.

Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E.

Blood. 2011 May 5;117(18):4852-4. doi: 10.1182/blood-2010-10-310995. Epub 2011 Mar 15.

46.

Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R.

Nature. 2011 Mar 10;471(7337):189-95. doi: 10.1038/nature09730.

47.

Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.

Marvin J, Swaminathan S, Kraker G, Chadburn A, Jacobberger J, Goolsby C.

Blood. 2011 Apr 14;117(15):e120-30. doi: 10.1182/blood-2010-10-316026. Epub 2011 Jan 13.

48.

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

Ruan J, Martin P, Furman RR, Lee SM, Cheung K, Vose JM, Lacasce A, Morrison J, Elstrom R, Ely S, Chadburn A, Cesarman E, Coleman M, Leonard JP.

J Clin Oncol. 2011 Feb 20;29(6):690-7. doi: 10.1200/JCO.2010.31.1142. Epub 2010 Dec 28.

PMID:
21189393
49.

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma.

Mandelbaum J, Bhagat G, Tang H, Mo T, Brahmachary M, Shen Q, Chadburn A, Rajewsky K, Tarakhovsky A, Pasqualucci L, Dalla-Favera R.

Cancer Cell. 2010 Dec 14;18(6):568-79. doi: 10.1016/j.ccr.2010.10.030.

50.

Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.

Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI.

Curr Oncol Rep. 2010 Nov;12(6):383-94. doi: 10.1007/s11912-010-0132-1. Review.

PMID:
20963522

Supplemental Content

Loading ...
Support Center